Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Global generics market to witness strong growth in the next few years

Industry Sector

Healthcare and Medical


21 December 2012


Mike King

Type of News


Revenues within the global generics market hit an estimated value of $162 billion in 2011, showing a growth of 9.3% throughout the year. This value amounts to representing approximately 19% of the generic market share in the international pharmaceutical market.

The generics market is experiencing two opposing trends driven by the global recession. On the one hand, the use of generics is increasing due to their cost-effectiveness and adoption has accelerated in markets where brand-name prescribing was dominant.

On the other hand, the squeeze on government spending has not left generics untouched with many countries lowering generics prices through cuts in reimbursement rates or contract tendering with a resultant pressure on margins.

Huge rewards and strong competition are prompting generic drug manufacturers to closely examine the best way to maximise market share as the industry patent cliff approaches its peak.

The revenues of drugs subject to patent expiration between 2013 and 2020 are valued at over US$100 billion, offering producers of generics and biosimilars a fantastic opportunity to substantially bolster their own sales.

Companies such as Hospira are reaching out to new locales in order to build a global presence, while targeting governments looking to bring down healthcare costs. Exploiting pharmaceutically underdeveloped economies may allow generics firms to launch products first, challenging the intellectual property of proprietary pharmaceutical majors.

Generics producers also hope to capitalise on expiring patents by manufacturing complex generics that are difficult to reproduce.

These "super generics" have high barriers to entry, a greater price than most other generics and incur greater R&D costs; however, there is significant potential for super generics within specific therapeutic areas, such as cancer and conditions involving the central nervous system.

The global generics market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide.

For more information on the global generics market, see the latest research: Global Generics Market

Follow us on Twitter @CandMResearch

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency


Change Currency


Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Black Friday Discounted Prices: Contact us to ask about our special discounts available today

It is Black Friday today and we are offering discounted prices on a selection of new reports. Please contact us on 00 44 (0) 203 0868600 or via email on to ask about prices and special discounts.

Available today on Black Friday; Discounted prices on a selection of our reports.


Contrast settings

Text size settings